Prof Bedossa discusses the definition of NAFLD / NASH and the role of liver biopsy. Liver biopsy cannot be used as a screening tool but is essential in clinical trials. To be useful, it has to be of a good quality and optimised. Prof Bedossa shares best practices in this regard.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In